MATERIAL AND METHODS
Eleven cases of chronic hypertrophic emphysema of varying severity were selected for study. The diagnosis was initially made on clinical and radiological grounds and was supported by lung function tests in each case (Table I) .
The tests included spirometry before and after an antispasmodic drug, with measurement of vital capacity (V.C.) and maximum breathing capacity (M.B.C.) and comparison of these values with predicted values for each patient (Baldwin, Cournand, and Richards, 1948) ; an estimate of functional residual capacity (F.R.C.) using a closed circuit constant volume apparatus of the type described by McMichael (1939) with certain modifications (Briscoe, Becklake, and Rose, 1951) ; calculation of residual volume (R.V.) and total lung capacity (T.L.C.); and comparison of these values with predicted values (Baldwin and others, 1948) ; estimation of mixing efficiency using an index of the type described by Becklake (1952) with correction for pulmonary deadspace (Becklake and Goldman, 1954) ; estimation of arterial oxygen saturation* at rest and after effort; and an estimation of red cell count, haemoglobin, and alkali reserve.
Patients were studied for an average period of 93 days (range six to 328 days) before the induction of a pneumoperitoneum during which period they received treatment with antibiotics, antispasmodics, and various forms of physiotherapy until it was thought that maximal improvement had been obtained. The function tests were repeated on several occasions (mean 5, range 3 to 13) during this preliminary observation period. In Table I the cases are arranged in order of clinical severity, the first two being the mildest and the last three bedridden. It will be seen that the group includes varying degrees of abnormality and that the pattern of abnormality is typical of " emphysema,"-for example, reduction in maximum breathing capacity, increased residual volume, impaired intrapulmonary mixing, and fall in arterial oxygen saturation on effort. Venous congestion was not a feature of any case at the beginning of the trial.
Pneumoperitoneum was induced while the patients were in hospital. One or two refills were carried out in hospital, and subsequently the pneumoperitoneum was maintained in the out-patient department for a mean period of 13 weeks (range two to 24 weeks). During this time lung function studies were repeated at intervals of two to four weeks, and again after the complete absorption of the pneumoperitoneum in most cases. In Case 1, the pneumoperitoneum was allowed to absorb after nine weeks, and was then re-induced for a further 12 weeks. Thus, two sets (Yule and Kendall, 1944 Zak and Southwell (1953) found the milder type of case responded better, other workers (Brackenridge and Jones, 1953; Furman and Callaway, 1950; Gaensler and Carter, 1950) were satisfied that good results could be obtained in the severe case. The amount of air introduced and the frequency of refills was less than that used by Furman and Callaway (1950) and by Zak and Southwell (1953) , but comparable to the series of Gaensler and Carter (1950) . Gaensler and Carter (1950) stated that maximal improvement in some cases could only be expected after some months of treatment, but their results show that measurable improvement could be observed within 17 days. In our series pneumoperitoneum was maintained for from 12 to 169 days (mean 87 days) during which time any improvement which the treatment could produce should have been observable in the tests done.
The most striking difference between this series and most of those reported in the literature lies in the method of judging improvement in the lungfunction tests. We have frequently observed the manner in which practice may produce improved values for tests such as vital capacity and maximum breathing capacity, and probably more important than this the way in which severity of symptoms (and results of function tests) fluctuate from week to week in any emphysematous subject (Becklake, McGregor, Goldman, and Braude, 1954) . There is thus a reasonable chance that a series of tests carried out on any two occasions will demonstrate " improvement " or " deterioration." It is only in the light of repeated testing before the beginning of the treatment to be assessed, with an estimation of the range of fluctuation for each test, that changes after the start of therapy can be assessed. The comparison of two tests, one carried out before and the other after the start of therapy, as reported by many workers, seems an inadequate method of assessment. Only in the series of Zak and Southwell (1953) The only other workers who report failure to produce objective evidence of improved lung function following pneumoperitoneum in the severe forms of chronic hypertrophic emphysema were Zak and Southwell (1953 
